Boston Scientific Corporation revenue for the last year amounted to 14.24 B USD, the most of which — 8.63 B USD — came from its highest performing source at the moment, Cardiovascular, the year earlier bringing 8.16 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Boston Scientific Corporation 8.43 B USD, and the year before that — 7.63 B USD.